- FDA advisory panel recommends approval of Merck's vorapaxar
- FDA approves liquid form of Merck HIV drug Isentress for infants, small children
- NACDS supports bill to curb Rx abuse, safeguard patients
- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- Industry players join Blue Button initiative
WHITEHOUSE STATION, N.J. Merck is expanding its patient assistance program, the drug maker said Wednesday.
Merck announced an expansion of the number of drugs it offers under its Merck Helps programs, including the Merck Patient Assistant program, the Merck Vaccine Patient Assistance program, the ACT program for cancer and hepatitis C drugs, and the SUPPORT program for HIV and AIDS drugs. The program provides medicines and vaccines free of charge to eligible patients, primarily the uninsured, who make up to 400% of the federal poverty level and can’t afford Merck drugs without assistance.
“Merck has historically recognized the critical need for people to have access to the prescription medicines and vaccines they require, even if they lose their insurance,” Merck EVP and chief medical officer Michael Rosenblatt said. “Our patient assistance programs now provide access to even more medicines for chronic conditions like asthma, diabetes and high blood pressure, allowing us to reach more people in need.”
Merck also said that its philanthropic arm, the Merck Company Foundation, made a grant to NeedyMeds, a nonprofit group that helps people who can’t afford medicines or healthcare costs by making information about assistance programs available. NeedyMeds plans to use the grant to translate its website into Spanish.